Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophagus Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04171141
What this trial is testing

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Who this might be right for
Gastrointestinal TumorsColorectal AdenocarcinomasGastric Adenocarcinomas+1 more
Pfizer 79
Early research (Phase 1)Looking for participantsNCT07179692
What this trial is testing

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

Who this might be right for
Lung CancerGastric CancerColon Cancer+3 more
Chongqing Precision Biotech Co., Ltd 108
Testing effectiveness (Phase 2)Study completedNCT00354679
What this trial is testing

Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00003864
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT02999893
What this trial is testing

APR-246 in Oesophageal Cancer

Who this might be right for
Oesophageal Carcinoma
Peter MacCallum Cancer Centre, Australia 5
Large-scale testing (Phase 3)Looking for participantsNCT05919030
What this trial is testing

Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Renmin Hospital of Wuhan University 155
Large-scale testing (Phase 3)UnknownNCT05049681
What this trial is testing

Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell

Who this might be right for
Esophageal Cancer
Feng Wang 234
Not applicableStudy completedNCT02324881
What this trial is testing

Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy

Who this might be right for
Head and Neck CancerPainLung Cancer+1 more
Vanderbilt-Ingram Cancer Center 24
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06152978
What this trial is testing

A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 182
Early research (Phase 1)Not Yet RecruitingNCT07196384
What this trial is testing

Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CW

Who this might be right for
Esophageal Cancer
University Medical Center Groningen 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621707
What this trial is testing

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Who this might be right for
Esophageal Squamous Cell CarcinomasConcurrent ChemoradiotherapyImmunotherapy+1 more
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05520619
What this trial is testing

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 114
Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Large-scale testing (Phase 3)Study completedNCT01107639
What this trial is testing

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Swiss Cancer Institute 297
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT04625543
What this trial is testing

Neoadjuvant Immunotherapy to ESCC

Who this might be right for
Esophagus SCC
Qilu Hospital of Shandong University
Early research (Phase 1)Not Yet RecruitingNCT07583316
What this trial is testing

First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more
Corregene Biotechnology Co., Ltd 192
Testing effectiveness (Phase 2)Looking for participantsNCT06172478
What this trial is testing

HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaHead and Neck Cancer+11 more
Daiichi Sankyo 740
Testing effectiveness (Phase 2)Study completedNCT01197885
What this trial is testing

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

Who this might be right for
Solid Tumors
Ganymed Pharmaceuticals GmbH 54
Next Page